» Articles » PMID: 33519990

[Histological Pulmonary Features Due to the Sars-CoV-2]

Overview
Specialty Pathology
Date 2021 Feb 1
PMID 33519990
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

The histological lesions associated with an infection with the Sars-CoV-2 are mainly observed at the respiratory tract level, but not exclusively. Analyses of these lesions strongly beneficied from autopsic studies allowing us to improve the knowledge of the pathophysiology mechanisms of this emerging infectious disease. Cytological analyses, notably those obtained from broncho-alveolar lavages, poorly contribute to the Covid-19 diagnosis, but can be usefull for eliminate a couple of differential diagnoses. Although non specific, the lesions observed in the pulmonary parenchyma can be directly associated with the presence of the Sars-CoV-2 thanks to ancillary tools allowing its detection. Indeed, the presence of the virus can be detected using immunohistochemistry, hybridization, molecular biology and/or electron microscopy approaches. Several uncertainties still exist concerning the direct role due to the Sars-CoV-2 in the observed lesions which can be due too to a cardiovascular failure and/or to the treatment(s) received in intensive care units. Thus, it is critical to keep going to increase our efforts for the tissue analyses, notably thanks to the autopsies of Covid-19 patients, in order to better understand the consequences of this infectious disease, and, particularly according the epidemiological factors and the different associated morbidities. An increased knowledge will participate to the further therapeutic strategies against the Covid-19. This review adresses the main histological lesions of the lung parenchyma currently described in patients infected by the Sars-CoV-2.

Citing Articles

Immunohistochemical and Morphometric Analysis of Lung Tissue in Fatal COVID-19.

Gheban-Rosca I, Gheban B, Pop B, Mironescu D, Siserman V, Jianu E Diagnostics (Basel). 2024; 14(9).

PMID: 38732328 PMC: 11082993. DOI: 10.3390/diagnostics14090914.

References
1.
Barton L, Duval E, Stroberg E, Ghosh S, Mukhopadhyay S . COVID-19 Autopsies, Oklahoma, USA. Am J Clin Pathol. 2020; 153(6):725-733. PMC: 7184436. DOI: 10.1093/ajcp/aqaa062. View

2.
Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C . Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020; 8(4):420-422. PMC: 7164771. DOI: 10.1016/S2213-2600(20)30076-X. View

3.
Varga Z, Flammer A, Steiger P, Haberecker M, Andermatt R, Zinkernagel A . Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020; 395(10234):1417-1418. PMC: 7172722. DOI: 10.1016/S0140-6736(20)30937-5. View

4.
Konopka K, Nguyen T, Jentzen J, Rayes O, Schmidt C, Wilson A . Diffuse alveolar damage (DAD) resulting from coronavirus disease 2019 Infection is Morphologically Indistinguishable from Other Causes of DAD. Histopathology. 2020; 77(4):570-578. PMC: 7323403. DOI: 10.1111/his.14180. View

5.
Mohanty S, Satapathy A, Naidu M, Mukhopadhyay S, Sharma S, Barton L . Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) - anatomic pathology perspective on current knowledge. Diagn Pathol. 2020; 15(1):103. PMC: 7427697. DOI: 10.1186/s13000-020-01017-8. View